Washington Trust Bank’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Washington Trust Bank’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-30	Closed	–	–	829
2015 Q3	$0	Hold	30	–	–	﹤0.01%	837
2015 Q2	$1K	Hold	30	–	–	﹤0.01%	785
2015 Q1	$1K	Hold	30	–	–	﹤0.01%	792
2014 Q4	$1K	Hold	30	–	–	﹤0.01%	843
2014 Q3	$1K	Buy	+30	New	+$780	﹤0.01%	802
2014 Q2	–	Sell	-30	Closed	-$1K	–	904
2014 Q1	$1K	Buy	+30	New	+$1.02K	﹤0.01%	820

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Washington Trust Bank's CTIC Position: Q4 2015 in Review

Washington Trust Bank sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2015, closing a stake of 30 shares.

Washington Trust Bank first reported a position in CTIC in Q1 2014 and held it in 6 quarters. The position peaked at $1K in Q2 2015. 94 funds tracked by Wall St. Rank hold CTIC as of Q4 2015.

Washington Trust Bank reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2015 after selling out during the quarter.
Washington Trust Bank sold 30 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2015.
Washington Trust Bank first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2014 and held it in 6 quarters.
Washington Trust Bank's CTI BioPharma Corp. (DE) Common Stock position peaked at $1K in Q2 2015.
94 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2015.

Based on Washington Trust Bank's 13F filing for Q4 2015, filed 21 Jan 2016.